author-photo

Lucia Kwak

Harvard University

7

Papers

22

Citations

Citation Trend

Filter By

Papers (6) Sort By

Journal Conference Others

Randomized phase II study evaluating the addition of pembrolizumab to radium-223 in metastatic castration-resistant prostate cancer.

2021 Journal of Clinical Oncology
Show All
- Source
- Cite
- Save
Citations (1)
Outcomes Post Neoadjuvant Intense Hormone Therapy and Surgery for Patients with High-Risk Localized Prostate Cancer: Results of a Pooled Analysis of Contemporary Clinical Trials.

2021 The Journal of Urology
Show All
- Source
- Cite
- Save
Citations (4)
Phase 2 multicenter study of enzalutamide in metastatic castration resistant prostate cancer to identify mechanisms driving resistance

2021 Clinical Cancer Research
Show All
- Source
- Cite
- Save
Citations (2)
Impact of Pathogenic Germline DNA Damage Repair alterations on Response to Intense Neoadjuvant Androgen Deprivation Therapy in High-risk Localized Prostate Cancer.

2021 European Urology
Show All
- Source
- Cite
- Save
Citations (3)
Prospective Evaluation of Clinical Outcomes Using a Multiplex Liquid Biopsy Targeting Diverse Resistance Mechanisms in Metastatic Prostate Cancer.

2021 Journal of Clinical Oncology
Show All
- Source
- Cite
- Save
Citations (4)
Post-radical prostatectomy (RP) outcome for patients with high-risk prostate cancer treated with intense neoadjuvant hormone therapy (NHT): Results of a pooled analysis of contemporary clinical trials.

2021 Journal of Clinical Oncology
Show All
- Source
- Cite
- Save
Citations (0)